Srinivas College of Pharmacy, Valachil, Farangipete post, Mangalore, 574143
The tropical tree Terminalia catappa L., also known as the Indian almond or tropical almond, is a member of the Combretaceae family and is found worldwide. The species, native to Asia, Australia, and Africa, is prized for its ethnomedicinal benefits, in addition to its aesthetic appeal and ecological relevance in coastal locations. The plant's leaves, bark, and seeds in particular have historically been used to treat conditions like diarrhea, liver problems, inflammation, and diabetes. This review provides a comprehensive synthesis of T. catappa's botanical identity, worldwide vernacular names, phytochemical composition, pharmacological activities, and toxicological safety profile. Its leaves tend to be abundant in bioactive components like triterpenoids (like ursolic acid), flavonoids (like isovitexin, rutin), and tannins (like punicalagin, corilagin). These components combine to give it a wide range of pharmacological properties, such as anti-inflammatory, anti-microbial, anti-aging, hepatoprotective, wound-healing, anticancer, and anti-oxidant properties. Its capacity to alter important genetic and metabolic pathways like SIRT1, AMPK, and Bcl-2 is demonstrated by preclinical research. A substantial safety margin is confirmed by toxicological tests, with LD?? values in rodents above 5000 mg/kg. At larger levels, subchronic exposure can cause modest liver changes. For commercial cultivation, future perspectives highlight the necessity of agro-economic methods, clinical validation through controlled trials, and bioassay-guided separation. For the development of evidence-based phytotherapeutics that target inflammatory, metabolic, and age-related illnesses, T. catappa appears to be a potential source.
Terminalia catappa L. is a huge tropical tree belonging to the Combretaceae family, and is indigenous to tropical regions of Australia, Africa, and Asia. Flowering plants of family Combretaceae include over 500 species and 14 genera [1]. There are 190 species in Terminalia, a few of which are economically significant as decorative plants and plants that yield timber. The generic name comes from the Latin word "terminalis," which describes the leaves clustering at the tips of the shoots [2]. Triterpenoids (ursolic acid, 2á, 3â, 23-trihydroxyurs-12-en-28-oic acid), flavonoids (isovitexin, vitexin, isoorientin, rutin), and tannins (punicalagin, punicalin, terflavins A and B, tergallagin, tercatin, chebulagic acid, geranin, granatin B, and corilagin) constitute the phytochemicals of this plant [3]. T. catappa L, frequently referred to as India almond or tropical almond, is a medium-sized to larger perennial tropical tree [1]. The tree has horizontal branches and an erect, homogeneous crown, reaching a height of 35 meters [2]. Wide propagating trees known as tropical almonds are currently prevalent throughout the coasts of the tropics. The species has historically played a significant role in coastal populations by offering a variety of non-wood goods and services [3]. Tropical almond is an underrated fruit that is high in vitamins, antioxidants, and pigments. Particularly, humans, birds, and animals consume their fruits [4]. Terminalia catappa leaves have been used for a variety of ethnomedical purposes. In Suriname, a tea prepared from the leaves is used to treat diarrhoea and dysentery. The leaves are also believed to have anti-cancer, antioxidant, and anticlastogenic properties, and Fallen leaves are used as an herb to cure liver conditions in Taiwan [5]. This study intended to explore Terminalia catappa L.'s medicinal potential, emphasizing its therapeutic applications and prospects in contemporary healthcare, given its broad pharmacological profile and historic usage.
Botanical identity [6]:
Taxonomical classification [7]:
Kingdom |
Plantae |
Phylum |
Magnoliophyta |
Class |
Magnoliopsida |
Subclass |
Rosidae |
Division |
Angiospermae |
Order |
Myrtales |
Family |
Combretaceae |
Genus |
Terminalia |
Species |
catappa |
VERNACULAR NAMES:
Table 1: Vernacular Names of Terminalia catappa by Geographic Region
Region / Country |
Language / Dialect |
Vernacular Name(s) |
Source (s) |
Indian Subcontinent |
|
|
|
India |
Assamese |
Kath-badam |
[8] |
|
Bengali |
Badam, Bangla-badam |
[8] |
|
Hindi |
Badam, Desi-badam, Jangli-badam, Patee badam |
[8] |
|
Kannada |
Kadubaadaami, Taree |
[8] |
|
Marathi |
Badam, Bengali Badam |
[8] |
|
Sanskrit |
Inguda, Ingudee, Grahadruma, Taapasataru |
[9] |
|
Tamil |
Nattuvadumai, Vadumai, Tani, Inkuti, Vatha kottai |
[8] |
|
Telugu |
Badamu, Nalu badami |
[9] |
Sri Lanka |
Sinhala |
Kottamba, Kottan |
[10] |
|
Tamil |
Nattuvadumai, Vadumai |
[10] |
Nepal |
Nepali |
Kaathe badaam |
[9] |
Southeast Asia |
|
|
|
Philippines |
Tagalog, Bisaya |
Talisai, Talisay, Taisi |
[9] |
|
Bicol |
Dalinsi |
[9] |
|
Ilokano (Ilk.) |
Logo, Lugo |
[9] |
|
Ivatan (Iva.) |
Savidug |
[9] |
|
Pampangan (Pamp.) |
Banilak, Dalasa, Hitam, Kalisai |
[9] |
Malaysia |
Malay |
Ketapang, Jelawai Ketapang, Telisai, Lingkak |
[11] |
Indonesia |
Indonesian |
Ketapang |
[12] |
|
Javanese |
Katapang |
[14] |
Vietnam |
Vietnamese |
Bàng, Bàng bi?n, Bàng nhóc, Mo c[uws]a, Bàng nu'ó'c |
[8] |
Thailand |
Thai |
Hu kwang, Khon, Taa-pang, Dat mue |
[8] |
Cambodia |
Khmer |
Châm'bâk barang', Kepang, Pareang |
[9] |
Laos |
Lao |
Huu kwaang, Somz moox dông |
[9] |
Myanmar |
Burmese |
Badan |
[8] |
Pacific Islands |
|
|
|
Fiji |
Fijian |
Tavola, Tivi |
[8] |
Guam, N. Marianas |
Chamorro |
Talisai |
[13] |
Hawaii |
Hawaiian |
Kamani haole, Kamani 'ula, False kamani |
[11] |
Papua New Guinea |
Pidgin |
Reddish-brown terminalia, Talis, Talise |
[9] |
Samoa |
Samoan |
Talie, 'Auali'i |
[14] |
Tonga |
Tongan |
Telie |
[9] |
Vanuatu |
Bislama |
Natapoa |
[8] |
Palau |
Palauan |
Miiche |
[13] |
General / Other |
|
|
|
|
English |
Indian Almond, Tropical Almond, Sea Almond, Beach Almond, Country Almond, Malabar Almond, Umbrella Tree |
[8] |
|
Spanish |
Almendro, Almendron, Almendrillo |
[8] |
|
French |
Badamier, Amandier des Indes |
[9] |
Description of the plant [15]:
Fig.no. 01: Leaves of Terminalia catappa L.
Fig.no. 02: Terminalia catappa L. Tree
Size
The medium- to large-sized Terminalia catappa L. tree can grow to a height of 25–40 m and has a similar crown spread when left in the open. The trunk's diameter at breast height reaches 50–150 cm at maturation.
Flowers
The blooms have a slightly nasty odor, are small (4-6 mm across), white or cream, have five lobes, and are placed on long (8-25 cm) axillary spikes. Only a few bisexual blooms are found around the base of a spike, with most of the flowers being male.
Leaves
The leaves are frequently clustered around the tips of the inverted branchlets, forming tight spirals. The leaf blade has five to twelve pairs of secondary veins and is simple, widely obovate, and is 8 to 25(-38) x 5 to 14(-19) cm (3 to 10[-15] × 2-61-7] in). The blunt, rounded leaf tip taper progressively to a narrow, subcordate base. A layer of soft, appressed brown hairs covers new leaves. Mostly glabrous (shiny), leathery, and dark green, mature leaves can become brilliant to dark crimson, then bright yellow, and finally fall.
Fruit
On the base of the flower spike, one to five fruits grow. The fruit is a smooth-skinned, ovoid to oblong, sessile drupe that is laterally compressed. When it reaches full maturity, its color shifts from green to yellow to either bright red or dark purplish-red. Fruits vary considerably in size, with the longest being 2.5 cm and the shortest being 10 cm. Encased in a subtle cream-colored, seldom red, testa, the kernel is made up of two delicate, intricately interwoven cotyledons.
Bark
The bark is shallowly cracked and ranges in color from gray to dark gray-brown.
Rooting habit
The lateral root system of the trees is often fibrous, spreading, and close to the surface. High water tables can cause the development of shallow lateral root systems.
Global distribution [15]:
Terminalia catappa L. is found naturally throughout tropical Asia, the Pacific Ocean, and near-coastal regions of the Indian Ocean. From the Seychelles, it stretches over Southeast Asia, India, the Andaman Islands, and nearby islands. Northern Australia, as far south as the Tropic of Capricorn, and Papua New Guinea. The species can be found throughout the South Pacific, including Fiji, Vanuatu, and the Solomon Islands. Brazil, the Caribbean, and East Africa are only a few of the tropical regions where Terminalia catappa L. has been introduced and often naturalized. Puerto Rico and Florida have recognized it as naturalized. The species was likely brought to Hawaii before 1800 and is already naturalized at low elevations, mostly along the shores of the beaches.
Traditional uses [16]:
Traditionally, Terminalia catappa L. (Combretaceae), also known as tropical almond or Indian almond, has been utilized as an antidiabetic, vermifuge, antioxidant, hepatoprotective, anti-inflammatory, and anti-cancer agent. Based on studies, the plant's leaves and bark contain chemopreventive, antidepressant, antifungal, anti-inflammatory, hepato-protective, and antioxidant properties. It has been previously documented that T. catappa L. extracts, when used as a component in topical treatments for wound healing, decreased the wound healing characteristics in rats. In animal models, the ethanol extract of T. catappa L. leaves displayed anti-inflammatory effects.
Bioactive constituents
According to the study, Terminalia catappa L. leaves included terpenoids, alkaloids, tannins, steroids, cardiac glycosides, flavonoids, phenols, saponins, and coumarins [17]. Punicalin, punicalagin, gallic acid, and a derivative of isovitexin were found in T. catappa leaves. Eleven chemical constituents, including gallic acid, catechin, chlorogenic acid, caffeic acid, ellagic acid, epicatechin, rutin, quercitrin, isoquercitrin, quercetin, and kaempferol, were also identified by chemical characterization of the phenolic-rich extracts of T. catappa. Additionally, the leaf and stem bark revealed eight chemical constituents, including gallic acid, catechin, caffeic acid, ellagic acid, resveratrol, rutin, quercetin, quercetin, and kaempferol phenolic compounds, respectively [18]. T. catappa seeds that have been air-dried have 52.02% fat, 25.42% protein, 14.6% fiber, and 5.98% sugar. Likewise, its gum is said to include uronic acids (19%), galactose (20%), arabinose (59%), mannose (1%), and xylose (1%). Phosphorus (P) is the most prevalent macro-element in T. catappa's defatted kernels (1804 mg/100g), followed by potassium (K) (1718 mg/100g), magnesium (Mg) (729.09 mg/100g), calcium (Ca) (415.01 mg/100g), and sodium (Na) (37.60 mg/100g). Iron (Fe) (16.15 mg/100 g) is the most abundant microelement, followed by manganese (Mn) (4.25 mg/100 g), copper (Cu) (4.63 mg/100 g), and zinc (Zn) (9.67 mg/100 g). Leucine, isoleucine, valine, phenylalanine, tryptophan, methionine, lysine, threonine, histidine, tyrosine, arginine, aspartic acid, glutamic acid, glycine, alanine, serine, cysteine, and proline are among the necessary amino acids that can be found in its nuts and seeds. Along with a few non-essential amino acids, the nectar of the flower contains the five essential amino acids—arginine, histidine, lysine, methionine, and threonine [4].
Fig. No. 03: Chemical constituents of Terminalia catappa L.
Pharmacological uses [2]:
Antimicrobial activity
The methanolic and chloroform extracts exhibit strong antibacterial action against both Gram-positive and Gram-negative bacteria. T. catappa root extract in chloroform exhibits antibacterial action against Staphylococcus aureus and Escherichia coli.
Anti-inflammatory, analgesic, and modulatory activity
In both acute and chronic animal models, ethanolic leaf extracts of T. catappa show an anti-inflammatory action on ear edema caused by 12-O-tetradecanoylphorbol-13-acetate (TPA).
T. catappa leaves were used to isolate a novel fetal hemoglobin-inducing chemical (T. catappa distilled water active fraction), which functions in concert with other compounds and has been shown to have a dual modulatory effect on intrinsic erythropoiesis. Tender leaf extract has been shown to have analgesic and anti-inflammatory properties without interfering with the estrous cycle. Additionally, the dosage does not result in sleepiness.
Wound?healing activity
When T. catappa ointment is applied to a wound, it is hypothesized that the area of the wound is reduced by 97% in comparison to the control (81%) and the conventional medication, betadine ointment. The accelerated induction of epithelialization by T. catappa ointment implies that the bark extracts have a significant wound-healing effect.
Antidiabetic activity
In animal models generated by alloxan, the aqueous and cold extract of fresh and tender leaves of T. catappa has the ability to lower lipids and elevated blood glucose levels. Histopathological research also supports its potential as an antidiabetic. Additionally, rats have been shown to exhibit hypocholesterolemic effects from T. catappa fruit extract and T. catappa fallen dry leaf decoction.
Antioxidant and radical scavenging activity
The DPPH, nirtic oxide, reducing power, and H2O2 assays have all shown that T. catappa has dose-dependent antioxidant activity.
Hepatoprotective activity
In patients with CCl4-induced liver injury, treatment with chloroform leaf extracts of T. catappa at concentrations of 20 mg/kg, 50 mg/kg, or 100 mg/kg dramatically lowers serum ALT, AST, and liver LPO levels. The hepatoprotective benefits are further confirmed by morphological inspection. This may point to a novel mechanism for T. catappa's hepatoprotective benefits.
Anticancer activity
The development of aberrant crypt foci and β-catenin-accumulated crypts may be inhibited by T. catappa, which has a strong short-term chemopreventive effect on a variety of biomarkers of colon carcinogenesis caused by the carcinogen azoxymethane. As a result, T. catappa might offer a potent chemopreventive agent against cancer.
Antiaging activity
T. catappa inhibited ERK, JNK, and p38 activation, which reduced the production of MMP-1, -3, and -9. Consequently, it can be applied as an anti-aging substance.
Toxicological and safety profile
It is impossible to overlook the potential for organ toxicity, including hepatotoxicity and nephrotoxicity, due to the unpredictable consumption of herbal products. Plant extracts' toxicological profiles are crucial for testing potential harm to living things in vivo and investigating the best ways to use them. In general, these tests of toxicity are essential for determining the level of risk in biological systems. evaluated the oral toxicity of Terminalia catappa aqueous leaf extract (TCA) in male Wistar rats, both acutely and subacutely. The Organization for Economic Co-operation and Development (OECD) classed TCA as practically non-toxic since its LD50 value was found to be higher than 5000 mg/kg bwt. Under OECD Test Guideline 425, the acute oral toxicity of T. catappa was also assessed in female albino Wistar rats. According to the study, the n-hexane extract's LD50 value is greater than 5000 mg/kg, demonstrating an outstanding safety profile and a low risk of toxicity from acute doses in animals [4].
Table 2: Summary of Toxicological Evaluations of T. catappa Leaf Extracts
Study Type |
Animal Model |
Extract Type |
Dosing Regimen |
Key Findings |
Source(s) |
Acute |
Male Wistar Rat |
Aqueous Leaf |
Single oral dose up to 5000 mg/kg |
LD50? > 5000 mg/kg; Practically non-toxic; No mortality or clinical signs of toxicity. |
[4] |
Acute |
Female Albino Wistar Rat |
n-Hexane |
Single oral dose up to 5000 mg/kg |
LD50? > 5000 mg/kg; Impressive safety profile for acute doses. |
[4] |
Acute |
Male Rat |
Aqueous Leaf |
Single oral dose of 2000 mg/kg |
LD50? > 2000 mg/kg; No mortality or signs of toxicity. |
[19] |
Sub-acute (28 days) |
Male Wistar Rat |
Aqueous Leaf |
Daily oral doses (200, 400, 800 mg/kg) |
No systemic toxicity; Altered body weight gain; Slight inflammatory diffusion in liver at higher doses. |
[20] |
Subchronic (30 days) |
Male Mice |
Water Leaf (Green & Brown) |
Daily oral doses (125, 250, 500, 750, 1000 mg/kg) |
Dose-dependent toxic effect on liver; Evidence of cell swelling and necrosis. |
[21] |
Sub-acute (21 days) |
Pregnant Wistar Rat |
Aqueous Leaf |
Daily oral doses (100, 200, 400 mg/kg) |
Maternal toxicity: Moderate hepatic vacuolation/necrosis; Slight tubular necrosis in kidney. Fetal: No toxicity observed. |
[19] |
Future Perspectives: From Preclinical Discovery to Standardized Phytomedicine
Terminalia catappa has reached an important junction. Centuries of conventional wisdom have been validated by the vast body of scientific data supporting its medicinal potential. Moving forward necessitates a change in emphasis from general, exploratory screening to clinical, mechanistic, and targeted research.
Future research should be directed toward:
Finally, Terminalia catappa is much more than just a folk cure. The bioactive ingredients in this intricate phytopharmaceutical system interact with key pathways involved in human health and illness. It has the potential to provide a fresh generation of evidence-based phytomedicines for treating some of the most important health issues of our day with targeted, thorough, and cooperative research.
CONCLUSION
Based to this thorough assessment, Terminalia catappa L. is a phytochemically rich plant with significant medicinal potential, and contemporary scientific research is gradually validating its long history of traditional use. It has a wealth of bioactive substances, including hydrolyzable tannins and flavonoids, which are concentrated in varying amounts in its leaves, bark, and fruit. These chemically explain the distinct ethnobotanical use of each component.
There is strong pharmacological evidence. A number of additional advantages, such as strong anti-inflammatory, hepatoprotective, and wound-healing qualities, seem to stem from the plant's strong antioxidant activity. Its capacity to alter the basic mechanisms behind human illness and aging is one of the most intriguing study fields. Its ability to lower blood sugar is associated with the suppression of digestive enzymes and, more significantly, with the overexpression of SIRT1, the master metabolic regulator. Targeted suppression of the anti-apoptotic protein Bcl-2 is thought to be the cause of its anticancer properties. Most remarkably, the AMPK signaling pathway, a key hub for cellular energy sensing and longevity, has been shown to mediate its anti-aging potential in C. elegans. These discoveries transform T. catappa from a conventional treatment into a source of compounds that engage with the same targets as state-of-the-art pharmaceutical studies.
REFERENCES
Sneha D., Ramdas Bhat, Terminalia catappa: A Review of Its Botanical Identity, Phytochemistry, And Clinical Potential, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 7, 2892-2900. https://doi.org/10.5281/zenodo.16274532